Introduction Thyroid Eye Disease (TED), also called Graves’ orbitopathy or thyroid-associated ophthalmopathy, is a rare, debilitating autoimmune disorder affecting approximately 1.9 per 10,000 people annually. TED typically progresses from an active inflammatory phase to a stable fibrotic (inactive) phase over 1–3 years, causing symptoms ranging fr